TY - JOUR
T1 - Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community
T2 - Determinants and detection of left ventricular dysfunction
AU - Costello-Boerrigter, Lisa C.
AU - Boerrigter, Guido
AU - Redfield, Margaret M.
AU - Rodeheffer, Richard J.
AU - Urban, Lynn H.
AU - Mahoney, Douglas W.
AU - Jacobsen, Steven J.
AU - Heublein, Denise M.
AU - Burnett, John C.
N1 - Funding Information:
Supported by grants HL-55502 and HL-36634 (Dr. Burnett) and HL-07111 (Dr. Boerrigter) from the National Institutes of Health, by the Miami Heart Research Institute, by the Mayo Foundation, by the Marriott Foundation, by a grant from the Vascular Biology Working Group (Dr. Costello-Boerrigter), and by a research grant from Roche Diagnostics (Dr. Burnett).
PY - 2006/1/17
Y1 - 2006/1/17
N2 - OBJECTIVES: This study sought to characterize factors influencing amino-terminal pro-B-type natriuretic peptide (NT-proBNP) and to evaluate the ability of NT-proBNP to detect left ventricular (LV) dysfunction in a large community sample. BACKGROUND: Secretion of BNP increases in cardiac disease, making BNP an attractive biomarker. Amino-terminal proBNP, a fragment of the BNP prohormone, is a new biomarker. We evaluated factors influencing NT-proBNP in normal patients and compared the ability of NT-proBNP and BNP to detect LV dysfunction in a large community sample. METHODS: Amino-terminal pro-BNP was determined in plasma samples of a previously reported and clinically and echocardiographically characterized random sample (n = 1,869, age <45 years) of Olmsted County, Minnesota. RESULTS: In normal patients (n = 746), female gender and older age were the strongest independent predictors of higher NT-proBNP. Test characteristics for detecting an LV ejection fraction ≤40% or ≤50% were determined in the total sample with receiver operating characteristic curves. Amino-terminal pro-BNP had significantly higher areas under the curve for detecting an LV ejection fraction ≤40% or ≤50% than BNP in the total population and in several male and age subgroups, whereas areas were equivalent in female subgroups. Age- and gender-adjusted cutpoints improved test characteristics of NT-proBNP. Both assays detected patients with systolic and/or moderate to severe diastolic dysfunction to a similar degree, which was less robust than the detection of LV systolic dysfunction alone. CONCLUSIONS: Amino-terminal pro-BNP in normal patients is affected primarily by gender and age, which should be considered when interpreting values. Importantly, in the entire population sample NT-proBNP performed at least equivalently to BNP in detecting LV dysfunction and was superior in some subgroups in detecting LV systolic dysfunction.
AB - OBJECTIVES: This study sought to characterize factors influencing amino-terminal pro-B-type natriuretic peptide (NT-proBNP) and to evaluate the ability of NT-proBNP to detect left ventricular (LV) dysfunction in a large community sample. BACKGROUND: Secretion of BNP increases in cardiac disease, making BNP an attractive biomarker. Amino-terminal proBNP, a fragment of the BNP prohormone, is a new biomarker. We evaluated factors influencing NT-proBNP in normal patients and compared the ability of NT-proBNP and BNP to detect LV dysfunction in a large community sample. METHODS: Amino-terminal pro-BNP was determined in plasma samples of a previously reported and clinically and echocardiographically characterized random sample (n = 1,869, age <45 years) of Olmsted County, Minnesota. RESULTS: In normal patients (n = 746), female gender and older age were the strongest independent predictors of higher NT-proBNP. Test characteristics for detecting an LV ejection fraction ≤40% or ≤50% were determined in the total sample with receiver operating characteristic curves. Amino-terminal pro-BNP had significantly higher areas under the curve for detecting an LV ejection fraction ≤40% or ≤50% than BNP in the total population and in several male and age subgroups, whereas areas were equivalent in female subgroups. Age- and gender-adjusted cutpoints improved test characteristics of NT-proBNP. Both assays detected patients with systolic and/or moderate to severe diastolic dysfunction to a similar degree, which was less robust than the detection of LV systolic dysfunction alone. CONCLUSIONS: Amino-terminal pro-BNP in normal patients is affected primarily by gender and age, which should be considered when interpreting values. Importantly, in the entire population sample NT-proBNP performed at least equivalently to BNP in detecting LV dysfunction and was superior in some subgroups in detecting LV systolic dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=30344446989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=30344446989&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2005.09.025
DO - 10.1016/j.jacc.2005.09.025
M3 - Article
C2 - 16412859
AN - SCOPUS:30344446989
VL - 47
SP - 345
EP - 353
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 2
ER -